News — MRC Weatherall Institute of Molecular Medicine

Illustration showing the structures of receptors on the surface of γδ T-cells, B cells and αβ T-cells.

Structure of a key “trigger” of the immune response solved

15 August 2024

18 teams in the MRC WIMM receive LEAF Sustainability awards

17 July 2024

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research laboratories to embed sustainability into their work.

WIMM Day 2024

28 June 2024

On Thursday 20th June 2024, the MRC Weatherall Institute of Molecular Medicine came together to share their research and celebrate the MRC WIMM community at Saïd Business School for WIMM Day 2024.

A seminar room full of people listening to a PhD student giving a research talk.

PhD Researchers shine at MRC WIMM Student Presentation Day

15 May 2024

On Tuesday 14th May, PhD students from across the institute gathered to present their research projects.

Illustration of the inside of the intestine showing individual cells.

Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects

13 May 2024

Nature Nanotechnology study introduces new and improved version of all-in-one coronavirus vaccine

7 May 2024

Immunology at the MRC WIMM

29 April 2024

For International Day of Immunology 2024, we spoke with three scientists from the MRC Translational Immune Discovery Unit about their research.

Professor Graham Ogg Receives Wellcome Discovery Award with International Team

16 April 2024

MRC TIDU Group Leader awarded funding for an international 8-year research programme from global charitable foundation Wellcome.

Novel pairing of integrins improves action of T cells on cancer cells to control tumour growth

3 April 2024

New research published in Nature Immunology showcases the collaborative efforts of MRC TIDU researchers to describe a novel pairing of integrins which could improve T cell control of cancer.

Report makes recommendations to remove interdisciplinary research barriers

5 March 2024

The X-Net project – a partnership between the Universities of Edinburgh, Dundee, and Oxford – publishes its recommendations following extensive consultation with the biomedical research community.